Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
551-02-003 / 551-02-003 ISMRM Abstract

Parenchymal Tissue Segmentation in a Multi-Vendor Chronic Kidney Disease Cohort

Accepted
Alexander J Daniel 1, Charlotte E Buchanan1, James P Stowe1, Eleanor F Cox1,2, Andrew N Priest3, David L Thomas4,5,6, Mark Gilthorpe7, Philip Kalra8, Iosif A Mendichovszky9, Steven Sourbron10, Maarten Taal11, Nicholas Selby11, Susan Francis1,2
1Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom
2NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom
3Department of Radiology, University of Cambridge, Cambridge, United Kingdom
4Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
5Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
6Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
7Obesity Institute, Leeds Beckett University, Leeds, United Kingdom
8Salford Royal NHS Foundataion Trust, Salford, United Kingdom
9Department of Radiology, Addenbrooke's Hospital, Cambridge, United Kingdom
10Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom
11Centre for Kidney Research and Innovation, University of Nottingham, Nottingham, United Kingdom
Presenting Author: Alexander J Daniel

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Qualification of Biomarker Total Kidney Volume in Studies for Treatment of Autosomal Dominant Polycystic Kidney Disease Draft Guidance for Industry. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/qualification-biomarker-total-kidney-volume-studies-treatment-autosomal-dominant-polycystic-kidney. Published September 16, 2016. Accessed October 21, 2025.
2. Daniel AJ, Buchanan CE, Allcock T, et al. Automated renal segmentation in healthy and chronic kidney disease subjects using a convolutional neural network. Magn Reson Med. 2021;86(2):1125-1136. https://doi.org/10.1002/mrm.28768 [doi]
3. Daniel AJ, Buchanan C, Morris DM, et al. Generalisability of Automated CNN-based Renal Segmentation for Multi-Vendor Studies. In: Proc. Intl. Soc. Mag. Reson. Med. 31. London; 2022:2160. https://doi.org/10.58530/2022/2160 [doi]
4. Francis ST, Buchanan CE, Alexander J Daniel, et al. The Application of FunctIonal Renal MRI to improve assessment of Chronic Kidney Disease (AFiRM) Study. In: Proc. Intl. Soc. Mag. Reson. Med. 33. Singapore; 2024:0779.
5. Buchanan CE, Li H, Nery F, et al. Harmonisation of Multiparametric Renal MRI for Multi-Centre Studies. In: Proc. Intl. Soc. Mag. Reson. Med. 30. Vol 29. Online; 2021:0417.
6. Will S, Martirosian P, Würslin C, Schick F. Automated segmentation and volumetric analysis of renal cortex, medulla, and pelvis based on non-contrast-enhanced T1- and T2-weighted MR images. Magn Reson Mater Phys Biol Med. 2014;27(5):445-454. doi:10.1007/s10334-014-0429-4 [doi]

Cite this abstract